ATS Stat

HomeATS Stat ▶ Stat Sept. 30, 2020
Stat Sept. 30, 2020

Last Day! Apply to be an ATS Fellow Today!

The ATS Fellow designation is a mark of distinction that recognizes the accomplishments, dedication, and contributions of ATS members to the Society and the fields of pulmonary, critical care, and sleep medicine.

If you have been an ATS member for five or more years, consider applying. Applicants must complete an application and submit two letters of reference in addition to a personal statement.

Deadline:  Sept. 30, 2020. Learn more!


Executive Order Mandating How to Address Race and Diversity: ATS Leadership Responds

On Sept. 22 the President signed an executive order titled “Combating Race and Sex Stereotyping”, which seeks to censor federal agency education efforts to address racial inequality in America. The executive order prevents the discussion of “divisive concepts” such as “race or scapegoating”, “race or sex stereotyping” or that “an individual, by virtue of his or her race or sex, bears responsibility for actions committed in the past by other members of the same race or sex.”

Respiratory health inequities, together with recent public protests, argue for more -not less- education and discussion about race and diversity.

Read the full statement here.


The ATS Recognizes World Lung Day

On Sept. 25, the ATS recognized World Lung Day (WLD), and joined with members of the Forum of International Respiratory Societies  and WLD partner organizations to advocate for respiratory health globally and call for more research to prevent, detect and treat respiratory infections. To learn more about World Lung Day and download the fact sheet, graphics and pledge campaign, go to the World Lung Day Toolkit.

Today is the last day to commemorate World Lung Day with us by joining the ATS Lung Run. Register and run today!


Upcoming Events!

Asthma and COVID-19: What Omics Can Tell Us About Risk Factors

When: 2 p.m. ET, Oct. 2, 2020
Register now! 


Upcoming Industry Innovations Webinars

Join us for, “A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma.”

Sponsored by GSK           

When: 6:30 p.m. ET, Oct. 6, 2020
Register now


Join us for, “A Path to Asthma Control: DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma” featuring Catherine Kier, MD.

When: 6:30 p.m. ET, Oct. 15, 2020
Register now!

Sponsored by Regeneron Sanofi Genzyme.

By registering for Industry Innovations webinars, you agree your information will be shared with the sponsor.


Deadline Tomorrow! AJRCCM Asthma Special Edition

Asthma is an area of high interest for the American Journal of Respiratory and Critical Care Medicine. Our 2019 special asthma issue had a large influence among the scientific community, with several articles included in the “Highly Cited” category by the Institute for Scientific Information.  

With a 2019 impact factor of 17.45, AJRCCM is increasingly better positioned to raise awareness in asthma research, and thus will publish a new special issue with original articles on topics related to asthma in adults and children in February 2021.  

We invite asthma scientists to submit original papers involving basic and translational research, epidemiological science, clinical trials, and community-based research.

Submissions must conform to the formatting requirements, and include a cover letter mentioning the special asthma-themed issue. Please contact Marc Bendian with questions.

Deadline: Oct. 1, 2020